Continuous Renal Replacement Therapy Market Size by 2030
< br>市場洞察とアナリストの見解:
このレポートには、現在の持続腎代替療法市場の動向と予測期間中の予測可能な影響による成長見通しが含まれています。
持続腎代替療法 (CRRT) )は、重度の急性腎障害(AKI)、体液過負荷、および致命的な可能性のある代謝異常を伴う尿毒症に苦しむ患者の命を救う介入です。小児用CRRT装置の需要の増加や腎疾患につながる慢性疾患の有病率の高さなどの要因が、継続的な腎代替療法市場の成長を推進しています。ただし、重大な腎臓有害事象 (MAKE) が発生する可能性が高く、市場の成長が制限されます。
市場の推進要因:
腎臓病につながる慢性疾患の発生率が高い
1世界中で 10 人が慢性腎臓病 (CKD) に罹患しています。CKD は一般的で生命を脅かす疾患です。 2015 年から 2019 年にかけて、腎不全の総症例の 75% において、糖尿病と高血圧が腎不全の 2 つの主な原因でした。 2020年に国立腎臓財団が発表した推計によると、米国では20歳以上の糖尿病人口の約30%が生涯にCKDを発症するリスクがあるとされています。さらに、この病気は 2020 年に前立腺がんや乳がんよりも多くの死亡者を引き起こしており、緊急の健康障害としてあまり認識されていません。アメリカ成人の 3 人に 1 人 (つまり、約 8,000 万人) が CKD のリスクにさらされており、現在、CKD は AKI の明らかな危険因子であると特定されています。糸球体濾過率 (GFR) の低下とタンパク尿の増加は、AKI と強く関連しています。
国立衛生研究所によると、先進国で AKI の発生が増加しています。病院の入院患者における有病率は 15% に達すると予測されており、重症患者ではさらに高く、60% となります。世界中の入院患者における AKI の発生率は 0.7% ~ 31% です。集中治療室 (ICU) にいる患者の発生率は 50% 以上です。 AKI患者の3%から13%の範囲でRRTが必要であり、これらの患者の40%は90日以上のCRRTが必要であると推定されています。したがって、腎臓病につながる慢性疾患の有病率が高いことが、継続的な腎代替療法市場の成長を後押ししています。
CRRTに関連する主な悪影響には、低血圧、頻脈、その他の不整脈があり、患者の状態や症状に悪影響を与える可能性があります。彼らの回復を妨げます。さらに、CRRT回路は微量栄養素、微量元素、および/または治療薬のより迅速なクリアランスを促進する可能性があり、これにより血液および組織中の濃度が低濃度または不規則になり、それによって悪影響および/または治療効果の損失が引き起こされる可能性があります。したがって、副作用は継続腎代替療法市場を制限します。
レポートの細分化と範囲:
継続腎代替療法市場分析は、以下によって実施されました。製品、モダリティ、エンドユーザーのセグメントを考慮します。
セグメント分析:
持続腎代替療法市場は、製品ごとに、透析液と補液、使い捨て、血液ラインセットに分類されます。チューブ、CRRT システム、血液フィルターなど。 CRRT システムセグメントは、2022 年に市場で最大のシェアを占めました。血液フィルターセグメントは、2022 ~ 2030 年に市場で最高の CAGR を記録すると予想されています。
継続的腎代替療法市場、製品別 - 2022 年および2030年
持続腎代替療法市場はモダリティ別に、持続静脈静脈血液濾過(CVVH)、持続静脈静脈血液透析濾過(CVVHDF)、持続静脈静脈血液透析(CVVHD)、および低速連続限外濾過(SCUF)に分類されます。持続的静脈静脈血液濾過 (CVVH) セグメントは、2022 年に市場で最大のシェアを占めました。持続的静脈静脈血液濾過 (CVVHDF) セグメントの市場は、2022 ~ 2030 年に最高の CAGR を記録すると予想されています。
エンドユーザー別、継続的腎代替療法市場は、病院、外来ケアセンター、在宅ケアなどに分割されています。 2022 年には、病院部門が継続腎代替療法市場シェアを独占しました。ただし、在宅モニタリングセグメントは、2022 ~ 2030 年に最も高い CAGR を記録すると予想されています。
地域分析:
持続的腎代替療法市場レポートの範囲には、北米 (米国、カナダ) が含まれます。 、メキシコ)、ヨーロッパ(スペイン、英国、ドイツ、フランス、イタリア、およびその他のヨーロッパ)、アジア太平洋(韓国、中国、インド、日本、オーストラリア、およびその他のアジア太平洋)、中東およびアフリカ(南部)アフリカ、サウジアラビア、アラブ首長国連邦、中東とアフリカのその他の地域)、南中米(ブラジル、アルゼンチン、中南米のその他の地域)。
収益の観点から見ると、2022 年には北がアメリカは継続腎代替療法の市場シェアを独占しました。アジア太平洋地域の市場は、2022 年から 2030 年にかけて最高の CAGR を記録すると予想されています。アジア太平洋地域の継続的腎代替療法市場は、医療インフラの改善と革新的な CRRT 技術の採用により成長しており、どちらも医療支出の増加に関連している可能性があります。さらに、地元の医療提供者との連携など、アジア太平洋地域での存在感を拡大するための市場参加者による戦略的取り組みが、この地域の市場成長を促進します。
競争環境と主要企業:
継続的腎代替療法市場レポートは、Baxter International Inc、旭化成、Fresenius Medical Care、Medica SpA、Medtronic Plc、B. Braun、日機装株式会社、東レ メディカル株式会社、Infomed SA などの市場の著名なプレーヤーに焦点を当てています。継続的な腎代替療法市場予測は、関係者が成長戦略を計画するのに役立ちます。これらの企業は、世界中で高まる消費者の需要に応えるために、新技術の導入、既存製品のアップグレード、事業の拡大に注力しています。
2022 年 4 月、米国食品医薬品局 (FDA) は、米国食品医薬品局 (FDA) の 510(k) 認可を取得しました。持続腎代替療法 (CRRT) での使用を目的とした Baxter International Inc. の ST セット。 ST セットは、PrisMax または Prismaflex コントロール ユニット (モニター) と一緒に使用する、半透膜を介して血液浄化を提供する、接続済みの使い捨ての体外 (体外) 回路です。2022 年 3 月に、ニプロ メディカル株式会社 (ニプロ)腎臓、血管、医療外科製品の大手メーカーおよびサプライヤーである同社は、米国での SUURDIAL DX 血液透析システムの商業発売を発表しました。 SURDIAL DX は、患者と臨床医に最適な透析治療体験を提供するために設計された最先端の血液透析システムです。この製品は日本で製造されており、ニプロの親会社であるニプロ株式会社の腎医療機器の革新における 35 年以上の専門知識に基づいています。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Continuous renal replacement therapy is an available renal replacement method that includes intermittent hemodialysis and peritoneal dialysis to provide renal support for critically ill patients with acute kidney injury, mainly patients who are hemodynamically unstable. It is intended to be applied for 24 hours or longer through continuous, slower dialysis. CRRT is performed through pump-driven venovenous extracorporeal circuits and acts as renal support through blood purification to allow solute and fluid homeostasis.
The continuous renal replacement therapy market majorly consists of players such as Baxter International Inc, Asahi Kasei, Fresenius Medical Care, Medica S.p.A., Medtronic Plc, B. Braun, Nikkiso Co Ltd, Toray Medical Co Ltd, Infomed SA, and Quanta Dialysis Technologies Inc.
US holds the largest market share in continuous renal replacement therapy market According to the Centers for Disease Control and Prevention in 2021, ~785,000 people in the US were living with end-stage kidney disease also known as end-stage renal disease; 71% out of these were undergoing dialysis while 29% had undergone kidney transplant procedures. As of 2020, there were nearly 7,500 dialysis clinics in the US. The increasing adoption of unhealthy food habits is one of the most prominent risk factor for numerous lifestyle-related disorders such as hypertension, diabetes, and kidney dysfunction.
The factors that are driving the growth of the market are the increased demand for pediatric CRRT devices and the high prevalence of chronic diseases leading to kidney diseases.
The continuous renal replacement therapy market, based on product, is segmented into dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. The CRRT systems segment held the largest share of the market in 2022.
The continuous renal replacement therapy market, based on modality, is continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). The continuous venovenous hemofiltration (CVVH) segment held the largest share of the market in 2022; however, the continuous venovenous hemodiafiltration (CVVHDF) segment is likely to register the highest CAGR.
Asia Pacific is expected to be the fastest-growing region in the continuous renal replacement therapy market. Improving healthcare infrastructure with rising expenditure and the adoption of innovative CRRT technologies bolster the continuous renal replacement therapy market size in Asia Pacific. Additionally, strategic initiatives by the market players to expand their presence in this region, including collaborations with local healthcare providers, favor the market growth in the region.
The continuous renal replacement therapy market, based on end user, is segmented into hospitals, ambulatory care centers, home care, and others. In 2022, the hospitals segment dominated the continuous renal replacement therapy market share. The home monitoring segment is expected to register the highest CAGR during 2022–2030.
The List of Companies - Continuous Renal Replacement Therapy Market
- Baxter International Inc
- Asahi Kasei
- Fresenius Medical Care
- Medica S.p.A.
- Medtronic Plc
- B. Braun
- Nikkiso Co Ltd
- Toray Medical Co Ltd
- Infomed SA
- Quanta Dialysis Technologies Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.